Douglas A. Dachille's Net Worth

$10.8 Million

Estimate Recalculated Jul 2, 2024 03:33PM EST

Who is Douglas A. Dachille?

Douglas A. Dachille has an estimated net worth of $10.8 Million. This is based on reported shares across multiple companies, which include AMERICAN INTERNATIONAL GROUP, INC., and BridgeBio Pharma, Inc..

SEC CIK

Douglas A. Dachille's CIK is 0001652908

Past Insider Trading and Trends

2018 was Douglas A. Dachille's most active year for acquiring shares with 20 total transactions. Douglas A. Dachille's most active month to acquire stocks was the month of February. 2019 was Douglas A. Dachille's most active year for disposing of shares, totalling 5 transactions. Douglas A. Dachille's most active month to dispose stocks was the month of December. 2022 saw Douglas A. Dachille paying a total of $245,584.00 for 124,921 shares, this is the most they've acquired in one year. In 2019 Douglas A. Dachille cashed out on 177,881 shares for a total of $2,569,120.76, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AMERICAN INTERNATIONAL GROUP, INC. (AIG) Snapshot price: $69.745

EVP and CIO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 29
Form 4
-50.00%
-63.44K
$53.23
-$1,049,271.73
63.44K
Jun 2
Form 4
—
0
—
—
0
Mar 30
Form 4
-17.10%
-26.17K
$45.96
-$1,202,957.04
126.87K
Mar 2
Form 4
+53.20%
53.14K
—
—
153.04K
Feb 22
Form 4
-9.82%
-10.88K
$41.35
-$449,888.00
99.9K
Jan 15
Form 4
+35.79%
29.2K
—
—
110.78K
Jan 1
Form 4
—
0
—
—
0
Dec 28
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 29
Form 4
—
0
—
—
0
Mar 30
Form 4
—
0
—
—
0
Mar 11
Form 4
-10.90%
-9.98K
$52.90
-$527,994.90
81.58K
Jan 17
Form 4
+39.56%
25.95K
—
—
91.56K
Jan 1
Form 4
—
0
—
—
0
Dec 26
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 28
Form 4/A
-0.62%
-407.00
$43.06
-$17,525.42
65.61K
Mar 29
Form 4
+1.27%
826
—
—
66.02K
Mar 29
Form 4
—
0
—
—
0
Mar 18
Form 4
+766.54%
57.67K
$44.04
-$2,464,742.64
65.19K
Mar 15
Form 4
-21.38%
-2.05K
$42.45
-$86,852.70
7.52K
Jan 18
Form 4
+155.86%
5.83K
—
—
9.57K
Jan 1
Form 4
—
0
—
—
0
Dec 26
Form 4
—
0
—
—
0
Sep 28
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Mar 29
Form 4
—
0
—
—
0
Mar 13
Form 4
-34.15%
-1.94K
$60.04
-$116,477.60
3.74K
Feb 23
Form 4
∞
5.68K
—
—
5.68K
Jan 17
Form 4
—
0
—
—
0
Dec 22
Form 4
—
0
—
—
0
Sep 29
Form 4
—
0
—
—
0
Sep 15
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Mar 29
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Dec 22
Form 4
—
0
—
—
0
Nov 8
Form 4
—
0
—
—
0
Sep 15
Form 3
—
0
—
—
0
No matching records found

BridgeBio Pharma, Inc. (BBIO) Snapshot price: $33.7899

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 22
Form 4
+100.00%
10K
$8.19
$81,934.00
20K
Mar 14
Form 4
∞
10K
$16.36
$163,650.00
10K
Jan 4 - Jan 5
Form 4
—
0
—
—
0
Aug 17
Form 3
—
0
—
—
0
No matching records found